title: Serum lipid profiles, total tract nutrient digestibility, and gastrointestinal tolerance by dogs of α-cyclodextrin.
abstract: The objectives were to quantify gastrointestinal tolerance, total tract nutrient digestibility, and serum lipid profiles of dogs as affected by α-cyclodextrin (ACD) supplementation and to validate the accuracy of fat analyses techniques using novel ACD-fat complexes. The ACD was hydrolyzed and free sugars and hydrolyzed monosaccharides were quantified using high performance liquid chromatography. Known amount of fats were complexed with ACD, and fat content of complexes were determined using the ether extraction and acid-hydrolyzed fat methods. Nine mixed-breed hounds were used in a crossover design with 3 periods of 10 d each, including 6 d for diet adaptation and 4 d for fecal collection. Dogs were fed twice daily a diet with poultry byproduct meal and brewer's rice as the main ingredients, and chromic oxide (0.2%) was included as a digestion marker. Dogs were supplemented with either 0, 3, or 6 g of ACD diluted in 15 mL of water twice per day for a total of 0, 6, and 12 g ACD per day. The ACD had a very low free sugar concentration and, once hydrolyzed, released only glucose, as expected. Average daily food intake, fecal output (DM basis), and fecal scores were not significantly different among treatments. Body weight and condition score and serum triglycerides and cholesterol concentrations remained unaltered throughout the duration of the experiment. Dry matter, OM, and fat digestibility coefficients were lower (P < 0.05) for both treatment groups compared to the control. The acid-hydrolyzed fat method was valid to measure fat that was bound to ACD. Intake of ACD lowered fat digestibility somewhat but not to the extent previously reported, without affecting serum lipid concentrations or outcomes related to tolerance. Therefore, ACD supplementation resulted in a small decrease in fat digestibility, but ACD supplementation might have potential in modifying serum lipid profiles.
authors.forename: M A
authors.initials: MA
authors.lastname: Guevara
authors.forename: L L
authors.initials: LL
authors.lastname: Bauer
authors.forename: K A
authors.initials: KA
authors.lastname: Garleb
authors.forename: G C
authors.initials: GC
authors.lastname: Fahey
authors.forename: M R C
authors.initials: MR
authors.lastname: de Godoy
mesh_terms: D000818:Animals; D018592:Cross-Over Studies; D004032:Diet / Q000662:veterinary; D004043:Dietary Fiber / Q000494:pharmacology*; D019587:Dietary Supplements; D004063:Digestion / Q000187:drug effects* / Q000502:physiology; D004285:Dogs / Q000378:metabolism*; D004435:Eating / Q000187:drug effects; D005223:Fats / Q000032:analysis; D005243:Feces / Q000737:chemistry; D041981:Gastrointestinal Tract / Q000187:drug effects* / Q000378:metabolism; D050356:Lipid Metabolism / Q000187:drug effects / Q000502:physiology; D008055:Lipids / Q000097:blood*; D009747:Nutritional Physiological Phenomena / Q000187:drug effects / Q000502:physiology; D047391:alpha-Cyclodextrins / Q000494:pharmacology*
chemical_list: D004043:Dietary Fiber; D005223:Fats; D008055:Lipids; D047391:alpha-Cyclodextrins; C032613:alpha-cyclodextrin